The industry’s crucial role in clinical trials has just been confirmed by a new study that estimated the COVID-19 vaccination program had prevented nearly 280,000 additional deaths and up to 1.25 million hospital stays by the end of June 2021.
“If there hadn’t been a vaccination program, the daily deaths from COVID-19 during a second ‘spring wave 2021’ would have potentially risen to almost 4,500 deaths per day – and thus would have dwarfed the daily high of 4,000 observed during the first winter wave 2021.” says the new Commonwealth Fund report.
“Clinical trial practitioners should be incredibly proud of their historic role in developing and distributing effective vaccines at record speed,” said Susan Landis, executive director of the Association of Clinical Research Professionals (ACRP). “Every step of the way, our members have helped accelerate and advance the pandemic response – from recruiting for and managing interventional studies to developing complex population health studies that will assess the long-term effects of COVID- 19 rate. Clinical researchers are the behind the scenes heroes who made COVID-19 research possible. “
“Our results show the tremendous impact of rapidly vaccinating large sections of the population in preventing hospitalizations and deaths … the speed of vaccination appears to have prevented another potential wave of the US pandemic in April,” the Commonwealth Fund report added .
The US has “supported the development of highly effective vaccines, issued emergency approvals and delivered the products at an unprecedented pace,” the study said.
The COVID-19 pandemic has caused nearly 4 million deaths worldwide, with more than 600,000 fatalities in the United States. By July 2, the US had given more than 328 million doses of the vaccine, with 67% of adults receiving at least one dose. The number of cases has dropped from more than 300,000 per day at the height of the pandemic in January 2021 to less than 20,000 per day as of mid-June.
Modifications made by Michael Causey